Topics
October 2015 | Special Focus: Uveitis
Promising Pipeline for Treatment of Noninfectious Posterior Uveitis
Agents and delivery mechanisms in development may offer physicians assistance in treating this heterogeneous disorder.
Steven Yeh, MD
November 6, 2026
VeonGen Therapeutics Secures FDA Alignment on Phase 3 Development of VG801 for Stargardt Disease
November 5, 2026
Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States
November 4, 2026
AEYE Health Wins 2026 Prix Galien USA Award for Autonomous AI Diabetic Retinopathy Screening Technology
November 3, 2026
Moorfields Eye Hospital Appoints Aruna Mehta as New Chair
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
